292 results on '"DI CARLO, Angelina"'
Search Results
2. Prep1 Deficiency Affects Olfactory Perception and Feeding Behavior by Impairing BDNF-TrkB Mediated Neurotrophic Signaling
3. Peptide-Specific Killing of Antigen-Presenting Cells by a Recombinant Antibody-Toxin Fusion Protein Targeted to Major Histocompatibility Complex/Peptide Class I Complexes with T Cell Receptor-Like Specificity
4. Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system
5. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
6. Expression of Beta-Catenin, Cadherins and P-Runx2 in Fibro-Osseous Lesions of the Jaw: Tissue Microarray Study
7. Iodine status assessment in Campania (Italy) as determined by urinary iodine excretion
8. The Tissue-Specific Pathways Regulating Cell Proliferation Are Inherited Independently in Somatic Hybrid between Thyroid and Liver Cells
9. Test sierologico per coadiuvare la diagnosi e il monitoraggio del glioblastoma multiforme
10. Sex Hormones and Inflammation Role in Oral Cancer Progression: A Molecular and Biological Point of View
11. Protein corona profile of graphene oxide allows detection of glioblastoma multiforme using a simple one-dimensional gel electrophoresis technique: a proof-of-concept study
12. Multifaceted Breast Cancer: The Molecular Connection With Obesity
13. Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading
14. Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas
15. MP08-05 LIQUID BIOPSY IN CLEAR CELL RENAL CELL CARCINOMA: URINARY MIR-210-3P AS EMERGING SPECIFIC BIOMARKER
16. Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis
17. Correction: Disease-specific protein corona sensor arrays may have disease detection capacity
18. Different forms of serum gelatinases in human intracranial neoplasms
19. Long term effects of mesoglycan on brachial arterial stiffness and MMP-9/TIMP-1 system in patients with metabolic syndrome
20. Exploitation of nanoparticle-protein interactions for early disease detection
21. The enigmatic role of matrix metalloproteinases in epithelial‐to‐mesenchymal transition of oral squamous cell carcinoma: Implications and nutraceutical aspects
22. Disease-specific protein corona sensor arrays may have disease detection capacity
23. Nanoparticle‐biomolecular corona: A new approach for the early detection of non‐small‐cell lung cancer
24. Expression of matrix metalloproteinase-9 in human glioma and meningioma
25. Circulating tumor cells in diagnosing lung cancer: clinical and morphologic analysis
26. Prep1 enhances neuronal activity by increasing insulin-like growth factor 1 pro-survival signalling
27. Matrix Metalloproteinasi-9: emergente biomarcatore nei meningiomi?
28. Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma
29. Serum levels of gelatinases, their inhibitors and neutrophil gelatinase-associated lipocalin: worthwhile non-invasive biomarkers for bladder cancer patients' managment
30. Malvidin's effects on blood brain barrier alterations during hypoperfusion/ reperfusion injury
31. Different forms of sera gelatinases in human intracranial neoplasias
32. Evaluation of matrix metalloproteinase-9 (MMP-9) and matrix metalloproteinse-2 (MMP-2) in sera of intracranial tumor patients
33. Nanoparticle‐biomolecular corona: A new approach for the early detection of non‐small‐cell lung cancer.
34. Substrate gelatin zymogrophy analysis of matrix metalloproteinase-2 and -9 (gelatinase A and B) in sera from patients with benign and malignant prostate disease
35. URINARY GELATINASE ACTIVITIES (MATRIX METALLOPROTEINASES 2 AND 9) IN HUMAN MENINGIOMA AND GLIOBLASTOMA
36. Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-9 (TIMP-1) in diagnosing pleural effusion of malignant origin
37. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and NGAL/MMP-9 (matrix Metalloproteinase-9) complex in urine of patients with bladder cancer
38. Role of WNT/beta-catenin up-regulation, cadherin alterations and up-runx2 expression in fibro-osseous lesions of the jaws. A tissue microarray study
39. Comparison of Different Detection In Vitro Techniques in the Molecular Diagnosis of Latex Allergy among Healthcare Workers
40. Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system
41. Multifaceted Breast Cancer: The Molecular Connection With Obesity
42. Malvidin’s Effects on Rat Pial Microvascular Permeability Changes Due to Hypoperfusion and Reperfusion Injury
43. Translational Research and Plasma Proteomic in Cancer
44. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma
45. Concentrations and activities of metalloproteinases-2 and-9 and their inhibitors (TIMPS) in oncocytoma and clear cell renal carcinoma
46. Gelatinolytic activities in sera and urine of human oncocytoma and renal cell carcinoma
47. Disease-specific protein corona sensor arrays may have disease detection capacityElectronic supplementary information (ESI) available. See DOI: 10.1039/c9nh00097f
48. Evaluation of matrix metalloproteinase-2 and -9 (gelatinase A and B) in the sera from patients with prostate diseases
49. Malattia neoplastica (Capitolo 20)
50. Gelatinolytic activities in the sera and in the urine from patients with prostate diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.